These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 6999021
1. Evaluation of cefamandole susceptibility testing of Enterobacteriacea by the autobac 1 system. de Girolami PC, Maher LA, Booth MT, St George DM. J Clin Microbiol; 1980 Oct; 12(4):546-9. PubMed ID: 6999021 [Abstract] [Full Text] [Related]
2. Interpretive criteria for cefamandole and cephalothin disk diffusion susceptibility tests. Barry AL, Schoenknecht FD, Shadomy S, Sherris JC, Thornsberry C, Washington JA, Kammer RB. Antimicrob Agents Chemother; 1979 Jan; 15(1):140-1. PubMed ID: 106770 [Abstract] [Full Text] [Related]
3. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics. George WL, Lewis RP, Meyer RD. Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524 [Abstract] [Full Text] [Related]
4. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study. Barry AL, Schoenknect FD, Shadomy S, Sherris JC, Thornsberry C, Washington JA, Kammer RB. Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998 [Abstract] [Full Text] [Related]
6. In vitro and in vivo studies with BL-S786, cefoxitin, and cefamandole. Shadomy S, Wagner G, Carver M. Antimicrob Agents Chemother; 1978 Mar; 13(3):412-5. PubMed ID: 400821 [Abstract] [Full Text] [Related]
7. In vitro comparison of synergism between cefamandole and gentamicin or tobramycin by the triple layer agar method with enzymatic inactivation. Yourassowsky E, Schoutens E, Van der Linden MP, Lismont MJ. Infection; 1979 Mar; 7(5):237-9. PubMed ID: 389805 [Abstract] [Full Text] [Related]
8. Antibacterial activity of cefamandole in vitro. Meyers BR, Hirschman SZ. J Infect Dis; 1978 May; 137 Suppl():S25-S31. PubMed ID: 349095 [Abstract] [Full Text] [Related]
10. [Susceptibility to first-generation Cephalosporins in Enterobacteriaceae isolated from urine culture according to CLSI and EUCAST breakpoints]. Corvalán V, Hervé B, Sanhueza C, Martínez N, Almonacid M, Fuente S. Rev Chilena Infectol; 2018 May; 35(3):329-331. PubMed ID: 30534916 [Abstract] [Full Text] [Related]
11. Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia. Beckwith DG, Jahre JA. J Clin Microbiol; 1980 Oct; 12(4):517-20. PubMed ID: 6968320 [Abstract] [Full Text] [Related]
12. Antagonism of cefamandole by cefoxitin in routine disk susceptibility tests. Sanders CC, Sanders WE. Am J Clin Pathol; 1980 Apr; 73(4):562-3. PubMed ID: 7369181 [Abstract] [Full Text] [Related]
16. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula. Esposito S, Galante D, Barba D. Chemioterapia; 1986 Apr; 5(2):101-4. PubMed ID: 3518963 [Abstract] [Full Text] [Related]
17. [The distribution of minimal inhibitory concentrations of recently introduced cephalosporins in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. as revealed by zone sizes of a standardized agar diffusion test (author's transl)]. Schröter G, Loch R. Zentralbl Bakteriol Orig A; 1979 Apr; 245(3):317-23. PubMed ID: 44786 [Abstract] [Full Text] [Related]
18. In vitro evaluation of cefoxitin and cefamandole. Adams HG, Stilwell GA, Turck M. Antimicrob Agents Chemother; 1976 Jun; 9(6):1019-24. PubMed ID: 820241 [Abstract] [Full Text] [Related]
19. Etest evaluation of enterobacteriaceae with reduced susceptibility to ciprofloxacin. Murphy O, Fairbairn C, Stewart D, Freeman R. J Antimicrob Chemother; 1997 Apr; 39(4):551-2. PubMed ID: 9145832 [No Abstract] [Full Text] [Related]
20. [Resistance of gram-negative bacteria against cefaclor and other antibiotics (author's transl)]. Schassan HH. Infection; 1979 Apr; 7 Suppl 6():527-31. PubMed ID: 399243 [Abstract] [Full Text] [Related] Page: [Next] [New Search]